McKinney Regional Cancer Care Center using the technology.
PROBEAT is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.
Facilitates material characterization, quantitative results
Department says hospital staff over-exposed patient in CT.
Centralized Data Management System platform for workflow efficiency
One last look at 2015 before you pop the champagne
Understanding your need for the right equipment is paramount to making an informed purchase decision
Defining the value with growing evidence
Research will focus on MR-guided radiotherapy, ultrasound
Bill creates limits, regulation on use of treatments.
Will continue to expand behavioral healthcare services
If you or a loved one has a condition that creates difficulty in clearing secretions from the lungs, you might need to purchase a used Cough Assist Device
There are various types of Traction Tables available, each designed to cater to specific therapeutic needs.
Brachytherapy pioneer chosen as ASTRO 2016 honorary member
Self-Referral of medical imaging exams is a primary factor in six-fold increase to Americans' radiation exposure from scans since 1980.
Device is the world's first proton therapy system capable of delivering pencil beam scanning at hyper speed
Midwest Infusion Center expanded from its previous space at West Health by opening a new infusion center at the City Center Professional Building in Plymouth for patients receiving infusion therapy.
Aims to replace 70% of its imaging equipment in the next five years
The Therapy Cool Path is the company's first irrigated ablation catheter in Japan.
NYI Langone Health appoints division chief of Hematology and Medical Oncology at Perlmutter Cancer Center-Sunset Park
Radiation therapy workshop to be held Feb. 1-3 in Orlando.
Fifty health care facilities and approximately 2,000 patients took part in an international clinical trial that revealed that physicians seldom apply available dose reduction strategies in procedures, which causes a wide variation in radiation exposure.
Philips and RXI team up for experimental therapy that uses ultrasound pulses to activate gene blockers.
Computed tomography (CT) angiography (CCTA) implicated in JAMA study.